期刊文献+

A key problem and challenge for hepatology:Obesity-related metabolic liver diseases

A key problem and challenge for hepatology:Obesity-related metabolic liver diseases
下载PDF
导出
摘要 With the arrival of the new millennium,gastroenterologists have been faced with the problem of metabolic liver diseases associated with obesity.The active role of the liver in metabolism and inflammation make it a key organ in the war against the rapidly-spreading worldwide epidemic of obesity.Many lives and much money could be saved if the work of hepatologists led to the development of effective diagnostic and therapeutic strategies against this growing leader of cirrhosis. With the arrival of the new millennium, gastroenterologists have been faced with the problem of metabolic liver diseases associated with obesity. The active role of the liver in metabolism and inflammation make it a key organ in the war against the rapidly-spreading world-wide epidemic of obesity. Many lives and much money could be saved if the work of hepatologists led to the development of effective diagnostic and therapeutic strategies against this growing leader of cirrhosis.
机构地区 Hacettepe University
出处 《World Journal of Hepatology》 CAS 2011年第6期142-146,共5页 世界肝病学杂志(英文版)(电子版)
关键词 METABOLIC liver diseases STEATOHEPATITIS OBESITY INSULINE resistance LIPOTOXICITY Adiposopaty. Metabolic liver diseases Steatohepatitis Obesity Insuline resistance Lipotoxicity Adiposopaty.
  • 相关文献

参考文献24

  • 1DeFronzo RA.Insulin resistance,lipotoxicity,type 2 diabetes and atherosclerosis: the missing links The Claude Bernard Lecture 2009. Diabetologia . 2010
  • 2CDC/NCHS.the National Health and Nutrition Examination Survey. http: //www. cdc.gov/nchs/data/hus/hus08.pdf . 2010
  • 3Koh HK.A 2020 vision for healthy people. The New England Journal of Medicine . 2010
  • 4http: //apps.who.int/bmi/index.jsp . 2010
  • 5Anis AH,Zhang W,Bansback N,Guh DP,Amarsi Z,Birming- ham CL.Obesity and overweight in Canada: an updated cost-of-illness study. Obesity Reviews . 2010
  • 6Lam B,Younossi ZM.Treatment options for nonalcoholic fatty liver disease. Therap Adv Gastroenterol . 2010
  • 7World population to 2300. http: //www.un.org/esa/po- pulation/publications/longrange2/WorldPop2300final.pdf . 2004
  • 8Jacobson IM,Davis GL,El-Serag H,Negro F,Trépo C.Pre- valence and challenges of liver diseases in patients with chro- nic hepatitis C virus infection. Clinics in Gastroenterology . 2010
  • 9Hill MJ,Metcalfe D,McTernan PG.Obesity and diabetes: lipids,’’nowhere to run to’’. Clinical Science Lond . 2009
  • 10Balistreri CR,Caruso C,Candore G.The role of adipose tis-sue and adipokines in obesity-related inflammatory diseases. Mediators of Inflammation . 2010

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部